The week of September 28 will be busy with plenty of market-moving economic data.

7 Monster Stock Market Predictions For The Week of September 28

September 27, 2020


Macro – SPY, GLD,

Mike’s Reading The Markets (RTM) Premium Content – NOW WITH A 2 WEEK FREE TRIAL


It will be a big week for stocks, with a lot of economic data that is likely to move markets. The S&P 500 finds itself in at a make or break moment as it nears a level of technical resistance at the upper end of its trading channel. If the S&P 500 futures can’t clear and hold above 3,312, it seems likely we head to 3,150.

Gold (GLD)

I also happen to think that gold will suffer as well, likely falling to $1,790.

Netflix (NFLX)

Netflix appears to be in a megaphone pattern, and that likely means it falls to the lower end of that pattern this week to around $450.

Micron (MU)

Micron will report results this week, and some bearish bets in the options market, indicate the stock falls to around $45.50. (Surging Volatility May Send Micron Shares Sharply Lower Following Results)

Nvidia (NVDA)

Nvidia has been flirting with breaking the uptrend for a couple of weeks, and if the market breaks this week, so will Nvidia, potentially falling to about $460.

Apple (AAPL)

Apple is facing stiff resistance at a downtrend too. Perhaps this is the week it finally breaks and falls to $96.

AT&T (T)

AT&T has been falling apart, with its next stop likely at $27.30.

Have a great Sunday, feeling a bit under the weather today, so keeping it short.


Mott Capital Management, LLC is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and, unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Past performance is not indicative of future results.